Researchers study planaria's regeneration process

Amputations trigger a molecular response that determines if a head or tail will be regrown in planaria, a flatworm commonly studied for its regenerative capabilities. Until now, no molecular connection between wounding and the decision to regenerate either a head or tail in planaria had been identified.

Whitehead Institute scientists report this finding in the September 15-28 issue of PNAS Early Edition.

Regeneration is the regrowth of part of an organism's body after it has been damaged or removed. Although animals such as planaria and starfish can regrow virtually any part of their bodies, humans have restricted regenerative capabilities. A better understanding of regeneration, including how the body decides which organs or tissues should be regrown after an injury, may eventually benefit patients with traumatic injuries, such as amputations or nerve damage.

To study how planaria regrow their bodies from a sliver of tissue, Christian Petersen, a postdoctoral fellow in Whitehead Member Peter Reddien's lab, looked at two of the planaria's genes, wntP-1 and wntP-2. These genes act to control cell to cell communication in a process called the Wnt signaling pathway, which is involved in many biological events, including development and growth. Petersen and Reddien had theorized that at least some portion of the Wnt pathway plays a role in regeneration.

In earlier work with planaria, Petersen and Reddien showed that a Wnt-related gene, called Smed-beta-catenin-1 (beta catenin), is necessary for planaria to regenerate a tail instead of a head after tail amputation. This ability to grow a head when the head is cut off and grow a tail when the tail is cut off is known as "regeneration polarity". In this experiment, Petersen cut the head, tail or both the head and tail off of planaria and observed where wntP-1 gene expression occurred.

Because previous experiments linked the Wnt-related gene beta catenin to proper tail regrowth, Petersen and Reddien expected that only the worms with amputated tails would express the wntP-1 gene. However, shortly after wounding the worms, a number of cells near both the head-facing and tail-facing wound sites expressed the wntP-1 gene.

"That was quite surprising, and it suggested that maybe wntP-1 is expressed at any wound," says Petersen. He then created a series of other wounds that did not remove an entire head or tail, and saw the same result: wntP-1 was expressed at all of the wound sites. After Petersen blocked the gene, only heads regrew in the place of tails, forming two-headed planaria. Investigating further, Petersen and Reddien found that in planaria with their tails cut off, the wntP-1 gene triggers beta-catenin, which activates the wntP-2 gene. If any of these steps is blocked, a head regrows instead of a tail.

Although Petersen and Reddien have figured out part of the regeneration process in planaria, the finding is only the beginning.

"We really want to understand the mechanism for how the polarity decision is made during regeneration - hos iw it specified that a the wound is facing the old head or facing the old tail?" asks Reddien, who is also an assistant professor of biology at Massachusetts Institute of Technology and a Howard Hughes Medical Institute (HHMI) early career scientist. "We think this question is very fundamental in understanding the determination of tissue identity. And this paper is an important step in understanding that mechanism."

Source: Whitehead Institute for Biomedical Research

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CRISPR-based therapy shown to be safe, effective for people with transthyretin amyloidosis